Details for Patent: 11,261,198
✉ Email this page to a colleague
Which drugs does patent 11,261,198 protect, and when does it expire?
Patent 11,261,198 protects XOFLUZA and is included in two NDAs.
This patent has twenty-six patent family members in seventeen countries.
Summary for Patent: 11,261,198
| Title: | Process for preparing substituted polycyclic pyridone derivative and crystal thereof |
| Abstract: | The present invention provides a process for preparing a compound of the formula (II): ##STR00001## wherein R.sup.2 is unsubstituted alkyl, characterized by reacting a compound of the formula (I): ##STR00002## wherein R.sup.1 is hydrogen or a protecting group other than unsubstituted alkyl, with a compound of the formula: R.sup.2--OH, wherein R.sup.2 is as defined above, in the presence of a sodium salt and/or a magnesium salt. |
| Inventor(s): | Shibahara; Setsuya (Amagasaki, JP), Anan; Kosuke (Toyonaka, JP) |
| Assignee: | SHIONOGI & CO., LTD. (Osaka, JP) |
| Application Number: | 16/310,897 |
|
Patent Claim Types: see list of patent claims | Compound; Process; |
Drugs Protected by US Patent 11,261,198
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | XOFLUZA | baloxavir marboxil | FOR SUSPENSION;ORAL | 214410-001 | Nov 23, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-001 | Oct 24, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-002 | Oct 24, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Genentech Inc | XOFLUZA | baloxavir marboxil | TABLET;ORAL | 210854-003 | Mar 18, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 11,261,198
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | JP2016-121453 | Jun 20, 2016 |
| PCT Information | |||
| PCT Filed | June 19, 2017 | PCT Application Number: | PCT/JP2017/022478 |
| PCT Publication Date: | December 28, 2017 | PCT Publication Number: | WO2017/221869 |
International Family Members for US Patent 11,261,198
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 108812 | ⤷ Try a Trial | |||
| Australia | 2017282305 | ⤷ Try a Trial | |||
| Brazil | 112018076600 | ⤷ Try a Trial | |||
| Canada | 3027840 | ⤷ Try a Trial | |||
| China | 109311911 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
